Article Details

Coherus BioSciences (NASDAQ:CHRS) Rating Increased to Hold at BidaskClub

Retrieved on: 2021-01-09 06:48:26

Tags for this article:

Click the tags to see associated articles and topics

Coherus BioSciences (NASDAQ:CHRS) Rating Increased to Hold at BidaskClub. View article details on hiswai:

Excerpt

The biotechnology company reported $0.33 earnings per share for the quarter, missing analysts' consensus estimates of $0.34 by ($0.01). Coherus ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up